Branş    Gastroenteroloji

Telefon    0216 444 0 353
    
Web Sitesi    http://www.erolavsar.com

Adres    Academic Hospital-Tıp Merkezi Nuh Kuyusu Cad. No: 94 Bağlarbaşı 34664 Üsküdar -İstanbul

İl/İlçe    İstanbul

Doktor Hakkında

Eğitim Bilgileri

Mezun Olduğu Okul

1979
Ege Üniversitesi Tıp Fakültesi
Lisans
Izmir
1991İstanbul Haydarpaşa Numune Hastanesi
İç Hastalıklar
Istanbul(Asya)
1995Marmara Üniversitesi Tıp Fakültesi
Gastroenteroloji
Istanbul(Asya)
1997Marmara Üniversitesi Tıp Fakültesi
İç Hastalıkları Anabilim Dalı Doçent
Istanbul(Asya)
2003Marmara Üniversitesi Tıp Fakültesi
İç Hastalıkları ve Gastroenteroloji Bilim Dalı Profesör
Istanbul(Asya)

İşDeneyimi

1985 - 1987    - Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı
1987 - 1991    - İstanbul Haydarpaşa Numune Hastanesi 2. Dahiliye Kliniği
1991 - Halen    - Marmara Üniversitesi Tıp Fakültesi Hastanesi Gastroenteroloji Bilim Dalı
İlgi Alanları
Karın ağrısı, sarılık, kronik ishal, kabızlık, patitler, siroz, peptik ülser, reflü hastalığı, sindirim sistemi kanamaları, de kanserleri, polipler, kolon kanserleri, ülseratif kolit, Crohn hastalığı, karaciğer kanserleri, safra yolları hastalıkları, gastroskopi, klonoskopi

Mesleki Üyelikleri

!stanbul Tabib Odası
Karaciğer Araştırmaları Derneği
Türk Gastroenteroloji Derneği
European Association Study of the Liver

Tıbbi Yayınlar

Hepatitler, Siroz ve komplikasyonları, Gastroözofageal reflü ve komplikasyonları, Peptik ülser-helikobacter pylori, Kapsül endoskopi, Sindirim sistemi kanserleri , Diagnostik ve terapötik endoskopi Bu konularda 100’ den fazla yerli ve yabancı yayın
1.Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E.
2.Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.Eren F, Yilmaz Y, Kose S, Ozdemir FT, Yonal O, Kurt R, Ozdogan O, Avsar E.
3.Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.Yilmaz Y, Eren F, Yonal O, Kurt R, Aktas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.
4.Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.
5.Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease.Yilmaz Y, Yonal O, Kurt R, Avsar E.
6.Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient.Arslan F, Tabak F, Avşar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R, Ferhanoglu B.
7.R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History.Eren F, Akkiprik M, Atuğ O, Sönmez O, Tahan G, Ozdemir F, Hamzaoğlu HO, Celikel CA, Imeryüz N, Avşar E, Ozer A.
8.The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey.Ozdemir FT, Tiftikci A, Sancak S, Eren F, Tahan V, Akın H, Gündüz F, Kedrah AE, Ustündağ Y, Avşar E, Tözün N, Ozdoğan O.
9.Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, Oflaz H, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.
10.Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, Ozdogan O, Duman D, Imeryuz N, Avsar E, Kalayci C.
11.Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, Avsar E, Turkoglu S, Midilli K, Tabak F, Ozturk R, Mert A, Senturk H, Tozun N.
12.The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.Canbakan B, Akin H, Tahan G, Tarcin O, Eren F, Atug O, Tahan V, Imeryuz N, Yapicier O, Avsar E, Tozun N.
13.Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.Tahan V, Atug O, Akin H, Eren F, Tahan G, Tarcin O, Uzun H, Ozdogan O, Tarcin O, Imeryuz N, Ozguner F, Celikel C, Avsar E, Tozun N.
14.Trial outcome and associative learning signals in the monkey hippocampus.Wirth S, Avsar E, Chiu CC, Sharma V, Smith AC, Brown E, Suzuki WA.
15.Role of capsule endoscopy in blue rubber bleb nevus syndrome.Barlas A, Avsar E, Bozbas A, Yegen C.
16.Effects of rosiglitazone on methionine-choline deficient diet-induced nonalcoholic steatohepatitis.Tahan V, Imeryuz N, Avsar E, Celikel C, Tozun N.
17.Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, Senturk O, Avsar E, Haklar G, Celikel C, Hulagu S, Tozun N.
18.Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death.Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, Akpulat S, Ozcelik D, Haklar G, Celikel C, Avsar E, Tozun N.
19.Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis.Tahan V, Eren F, Avsar E, Yavuz D, Yuksel M, Emekli E, Imeryuz N, Celikel C, Uzun H, Haklar G, Tozun N.
20.Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.Ozdemir FT, Duman D, Ertem D, Avşar E, Eren F, Ozdoğan O, Kalayci C, Aslan N, Bozdayi AM, Tözün N.
21.Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?Duman DG, Celikel C, Tüney D, Imeryüz N, Avsar E, Tözün N.
22.Prothrombotic gene mutations and Crohn's disease; is there any association?Over-Hamzaoglu H, Abaci N, Türe F, Alkim C, Tezel A, Avsar E, Tözün N.
23.Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys.Güney Duman D, Tüney D, Bilsel S, Benli F, Karan S, Avsar E, Ozdogan O, Tözün N.
24.Sexual transmission of HCV between spouses.Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N.
25.D-dimer--can it be a marker for malignant gastric lesions?Aliustaoglu M, Yumuk PF, Gumus M, Ekenel M, Bolukbas F, Bolukbas C, Mutlu N, Basaran G, Avsar E, Turhal NS.
26.Prevalence of hepatic granulomas in chronic hepatitis B.Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N.
27.Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet.Tahan V, Yavuz D, Imeryuz N, Avsar E, Tozun N.
28.Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy.Avsar E, Empson RM.
29.Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury.Gencosmanoglu R, Kurtkaya-Yapicier O, Tiftikci A, Avsar E, Tozun N, Oran ES.
30.The prevalence of hepatic granulomas in chronic hepatitis C.Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E, Ozbay G, Celikel CA, Tozun N, Senturk H.
31.Anti-HCV seroprevalence in chronic HCV patients' children in Turkey.Tahan V, Yildirim B, Ture F, Giral A, Ozdogan O, Imeryuz N, Avsar E, Mert A, Senturk H, Kalayci C, Tozun N.
32.The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, Bakirci N, Tozun N, Sav A.
33.Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.Tahan V, Avsar E, Karaca C, Uslu E, Eren F, Aydin S, Uzun H, Hamzaoglu HO, Besisik F, Kalayci C, Okten A, Tozun N.
34.Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients.Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N.
35.Effects of selective COX-2 inhibitors on the gastric permeability of sucrose: a controlled study with placebo and ibuprofen.Ekenel M, Avşar E, Imeryüz N, Yüksel M, Haklar G, Kocakaya O, Tözün N.
36.[The incidence of Usher's syndrome and its clinical types]Bereketoğlu M, Avşar EU, Turan O, Afrashi F, Apaydin F.
37.Prevalence of TT virus in a CAPD population.Ozener IC, Ture F, Koc M, Avsar E.
38.Close association between HCV infection and cryoglobulinemia in patients on chronic hemodialysis.Kilinç E, Aydin N, Sevinç AA, Avşar E, Ekmekçioglu C.
39.The effect of alpha interferon therapy and short-interval intradermal administration on response to hepatitis B vaccine in haemodialysis patients.Ozener C, Fak AS, Avşar E, Cinar S, Lawrence R, Akoğlu E.
40.Thrombophilia and inflammatory bowel disease: does factor V mutation have a role?Over HH, Ulgen S, Tuğlular T, Tezel A, Avşar E, Geyik G, Başgül S, Sayhan N, Ulusoy N, Kalayci C, Tözün N.
41.Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy.Avşar E, Savaş B, Tözün N, Ulusoy NB, Kalayci C.
42.Toothpick impaction: treatment by colonoscopy.Over HH, Tözün N, Avşar E.
43.Hyperglycemia-induced attenuation of rectal perception depends upon pattern of rectal balloon inflation.Avşar E, Ersöz O, Karişik E, Erdoğan Y, Bekiroğlu N, Lawrance R, Akalin S, Ulusoy NB.
44.Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.Avsar E, Kalayci C, Tözün N, Lawrence R, Kiziltas S, Gültekin O, Ulusoy NB.

Özel Veriler

İngilizce biliyorum.